Allergic bronchopulmonary aspergillosis presumably unmasked by PD-1 inhibition.

Authors

Anthony A Donato, Reading Hospital-Tower HealthFollow
Ronald Krol, Reading Hospital-Tower Health

Document Type

Article

Publication Date

2-13-2019

Abstract

Programmed cell death-1 (PD-1) inhibitors stimulate immune recognition of tumour cells in cancer patients, but have significant autoimmune side effects including pneumonitis. We report the case of a patient with asthma and mild eosinophilia who developed unusual pulmonary side effect of bronchiectasis, severe eosinophilia (absolute eosinophil count: 3200 c/mm

Publication Title

BMJ Case Rep

Volume

12

Issue

2

Recommended Citation

Donato, A., & Krol, R. (2019). Allergic bronchopulmonary aspergillosis presumably unmasked by PD-1 inhibition.. BMJ Case Rep, 12 (2) https://doi.org/10.1136/bcr-2018-227814